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Objectives. We sought to compare the accuracy of biphasic and
ischemic responses and sustained improvement for reversible
dysfunction and to identify causes of false negative and false
positive findings.
Background. Previous studies have shown that low dose dobut-
amine echocardiography was accurate for detecting reversible
dysfunction after acute myocardial infarction (MI) but did not
determine whether accuracy was improved by peak dose findings
or influenced by the test interval or clinical or angiographic
factors.
Methods. Dobutamine-atropine stress echocardiography (DASE)
(baseline, low dose [5 and 10 mg/kg body weight per min] and
peak dose) and coronary angiography were performed in 115
patients 2 to 7 days after MI (test interval). Segmental wall
thickening was analyzed according to the 16-segment model.
Sustained improvement and biphasic and ischemic responses
included improved wall thickening at low and peak doses, im-
proved wall thickening at the low dose with worsening at peak
dose and no change in wall thickening at the low dose with
worsening at peak dose, respectively. Follow-up echocardiography
was performed at 4 to 8 weeks, and reversible dysfunction was
defined as improved wall thickening.
Results. Wall thickening improved at follow-up in 305 (44%) of
688 dysfunctional segments. The test interval was 2 days in 16
patients, 3 days in 24, 4 days in 24, 5 days in 12, 6 days in 16 and
7 days in 23. No change at low and peak doses accurately predicted
fixed dysfunction (318 [88%] of 360 segments), especially in
akinetic and dyskinetic segments (276 [91%] of 303), irrespective
of the test interval or clinical and angiographic factors. Ischemic
segmental responses also predicted fixed dysfunction (63% [12 of
19 patients]), especially in medically treated compared with
revascularized patients (100% [8 of 8] vs. 36% [4 of 11], p 5
0.013). Both biphasic responses and sustained improvement (77%
[179 of 231 segments] vs. 87% [84 of 97], p 5 0.082) were highly
predictive of reversible dysfunction, especially in akinetic seg-
ments, irrespective of the test interval or clinical and angio-
graphic factors. The only limitation was reduced accuracy (77%
[177 of 222 segments], p < 0.001) due to false positive results
(16%) in hypokinetic segments.
Conclusions. No change and ischemic responses during DASE
were specific for fixed dysfunction. Improved wall thickening at
the low dose, irrespective of changes at peak dose, was highly
predictive of reversible dysfunction. Accuracy was only limited by
false positive results in hypokinetic segments and not by the test
interval or clinical or angiographic factors.
(J Am Coll Cardiol 1997;30:1669–78)
©1997 by the American College of Cardiology
Myocardial dysfunction resulting from acute myocardial infarc-
tion (MI) may be reversible or irreversible, depending on
myocardial oxygen demand, collateral blood flow and the
timing of reperfusion (1,2). Postischemic injury due to early
reperfusion or high collateral blood flow is the major mecha-
nism of reversible dysfunction. Recovery is often spontaneous
and evolves over the first 4 to 6 weeks (1–5). The mechanism
differs from patients with chronic left ventricular dysfunction,
in whom 1) reduced coronary blood flow or repetitive ischemia
is the major mediator, and 2) recovery occurs only after
revascularization (6–10). The determinants of reversible dys-
function are well known in patients with chronic dysfunction
(8–12), but clinical and angiographic factors, rest function and
the timing of testing may also affect the detection and inci-
dence of reversible dysfunction after acute MI (13).
Dobutamine-atropine stress echocardiography (DASE) is
predictive of reversible dysfunction in both patients with acute
MI and those with chronic left ventricular dysfunction due to
coronary artery disease (14–20), but the predictive value of its
multiple responses at low and peak doses is only known in the
latter group. Ischemic and biphasic responses are predictive of
reversible dysfunction, whereas sustained improvement at low
and peak doses is predictive of fixed dysfunction (21). Previous
studies have shown that no change and improved wall thick-
ening at the low dose identified fixed and reversible dysfunc-
tion, respectively, early after acute MI, but did not 1) deter-
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mine whether changes from low to peak dose improve
predictive accuracy; 2) identify the causes of false positive and
false negative results; or 3) evaluate whether accuracy was
limited by its interval from the onset of acute MI (16–20).
The objectives of the present study of DASE early after
acute MI were to 1) compare the predictive values of ischemic
responses, biphasic responses and sustained improvement for
reversible dysfunction; and 2) identify the causes of false
negative and false positive results and the limitations of DASE.
To investigate these aims, 115 patients underwent DASE and
coronary angiography during the first week after acute MI and
follow-up echocardiography 4 to 8 weeks later.
Methods
Patient selection. Between June 1992 and January 1995,
220 patients were admitted to the hospital for acute MI
according to the criteria of prolonged chest pain, total creatine
kinase (CK) and CK-MB .2 SD above normal and a wall
motion abnormality. The study was approved by the Institu-
tional Review Committee. Fifteen patients were excluded
because testing was performed .7 days after infarction. An-
other 67 patients were excluded because of nonconsent (n 5
25), technically poor images (n 5 2), recurrent hemodynamic
instability (n 5 20), angina (n 5 10) or sustained ventricular
arrhythmias requiring intravenous medical therapy (n 5 10).
The 138 enrolled patients gave written, informed consent and
underwent DASE. Twenty-three patients failed to return for
follow-up echocardiography.
Dobutamine-atropine stress echocardiography. Patients
were studied 2 to 7 days after acute MI with continuous 12-lead
electrocardiographic monitoring. Medical therapy was not
altered on the day of the test. Dobutamine was stepwise
infused at 5, 10, 20, 30 and 40 mg/kg body weight per min
(16–20,22). Atropine (0.2 to 0.4 mg every 2 min to a maximum
of 2 mg) was infused to achieve peak heart rates .120
beats/min 1) if the heart rate was submaximal at maximal
dobutamine, or 2) if cyclic variability in heart rate .10
beats/min, hyperdynamic wall motion (end-systolic left ventric-
ular diameter (,1 cm) or nausea with retching occurred at
submaximal doses of dobutamine. Imaging was started and
blood pressure measured at 5 min of each stage (22). The
dobutamine infusion was increased after imaging at 5 and
10 mg/kg per min and at 5 min thereafter. The stage duration
was 5 to 9 min (average 7 min) for 5 and 10 mg/kg per min and
5 min thereafter.
End points for dobutamine infusion were maximal dose,
heart rate $120 beats/min, limiting chest pain, headaches,
nausea with vomiting, $2 mm ST segment depression without
elevation compared with baseline in two or more leads, systolic
blood pressure ,90 or $240 mm HG, ventricular tachycardia
(more than five complexes at cycle lengths ,500 ms) or
sustained supraventricular tachyarrhythmias (23). Intravenous
esmolol (0.1 to 0.5 mg/kg every 2 min up to 1.5 mg/kg) or
sublingual nitroglycerin (0.4 mg every 5 min up to three doses),
or both, were administered after stopping the infusion if chest
pain was severe or did not resolve within 4 min.
Images were digitized on-line with a TomTec R-wave–
triggered system at baseline, 5 and 10 mg/kg per min and peak
dose (22). Images were digitized from the parasternal long-axis
and short-axis planes and apical four-chamber, two-chamber
long-axis and short-axis planes and arranged in a quad screen,
continuous loop format. Endocardial borders, including the
apex, were visualized in all patients. All studies were graded as
average or above average in image quality.
Dobutamine echocardiograms were interpreted by two
investigators who had no knowledge of the clinical or angio-
graphic data. All stages were directly compared. Videotape
recordings were made available. Each stage was analyzed
according to the previously described 16-segment model and
scoring system (22). Inadequately visualized segments were not
scored. Hypokinesia was defined as reduced thickening; akine-
sia as near or total absence of thickening; and dyskinesia as
paradoxic endocardial excursion away from the left ventricle
chamber and systolic thinning. Infarction zone segments were
identified by the previously described algorithm (Fig. 1) of
vascular territories (16). Improved segmental thickening was
the induction of wall thickening in akinetic or dyskinetic
segments or normalization of wall thickening in hypokinetic
segments, but not a change from dyskinesia to akinesia (16).
Sustained improvement was improved wall thickening in dys-
functional segments at low and peak doses. A biphasic re-
sponse was improved wall thickening at the low dose followed
by worsening at peak dose. An ischemic response involved
hypokinetic segments that did not change at low dose but
worsened at peak dose. Scar was reduced wall thickness with
moderate to markedly increased echogenicity (24).
In addition to segmental analysis, studies were also ana-
lyzed according to the main response or the dysfunctional
segments of the infarct-related vascular territory or infarct
zone (16,22). A similar response in three or more contiguous
segments was the criterion for ischemic responses, biphasic
responses and sustained improvement. A mixed response was
a combination of biphasic responses and sustained improve-
ment in a sum of three or more segments. All other combina-
tions were considered unchanged. The focus of this study was
reversible dysfunction after acute MI, so remote wall motion
abnormalities were not analyzed.
Follow-up echocardiography. Follow-up echocardiography
was performed 4 to 8 weeks after hospital discharge and
digitized as stated earlier (15–20,25). Images were separately
analyzed by two investigators who had no knowledge of the
clinical, dobutamine echocardiographic or angiographic data.
Abbreviations and Acronyms
CK 5 creatine kinase
DASE 5 dobutamine-atropine stress echocardiography
MI 5 myocardial infarction
ROC 5 receiver operating characteristic
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Follow-up images were directly compared with corresponding
baseline images. Reversible dysfunction was improved wall
thickening at follow-up (16–20). Dyskinetic segments changing
to akinetic segments were also evaluated as a criterion for
reversibility (16–20,26). Infarct zone dysfunction was defined
as reversible if wall thickening improved in three or more
segments.
Coronary angiography. Coronary angiography was per-
formed by the Judkin’s technique in all patients within the first
week after MI. All coronary stenoses were evaluated by an
investigator who was unaware of the other data. The culprit
lesion was identified by criteria for thrombus or stenosis
severity, or both. The frame and view with the smallest lumen
diameter were identified. Percent lumen diameter stenosis was
derived by the caliper technique. Infarct-related artery stenosis
was a lumen diameter stenosis $50% and occlusion 100% with
Thrombolysis in Myocardial Infarction (TIMI) flow grade 0 or
a subtotal occlusion with TIMI flow grade 1 (27). Percutaneous
transluminal coronary angioplasty or coronary artery bypass
graft surgery was performed at the discretion of the patient’s
cardiologist. Collateral channels were present if the score was
$2 by the following scale: 0 5 none; 1 5 minimal with partial
filling of the infarct-related artery; 2 5 moderate with delayed
complete filling; and 3 5 abundant with rapid complete filling
(28).
Statistical methods. Continuous data were expressed as
the mean value 6 SD. Continuous data were compared by
analysis of variance and the Bonferroni t test. Chi-square
analysis or the Fisher exact test was used to compare the
predictive values of the segmental responses for reversible
dysfunction. Computer-driven multiple logistic regression
analysis was used to identify independent predictors of revers-
ible dysfunction. Then, stepwise multiple logistic regression
analysis and receiver operating characteristic (ROC) analysis
were used to determine the incremental value of clinical (step
1), rest echocardiographic (step 2) and DASE data (step 3) in
the detection of reversible dysfunction (29). The kappa statistic
and the Fisher z test were used to assess intraobserver and
interobserver variability in a randomly selected series of 100
patients. Statistical significance was set at p , 0.05 (two-
tailed).
Results
Patient and coronary angiographic data. There were 98
men and 17 women with a mean age of 57 6 13 years. Twenty
patients had a previous MI. Treatment included thrombolytic
therapy in 79 patients, angiotensin-converting enzyme inhibi-
tors in 26 and beta-adrenergic blocking agents in 59. Infarction
location was anterior in 51 patients. Q waves evolved in 66
patients. Mean peak CK was 2,187 6 1,965 IU/ml.
The culprit lesion was within the left anterior descending
coronary artery in 51 patients (44%), left circumflex artery in
24 (21%) and right coronary artery in 40 (35%). Fifty patients
(43%) had multivessel disease (left circumflex and right coro-
nary artery disease in 10, left anterior descending and right
coronary artery disease in 16, left anterior descending and left
circumflex coronary artery disease in 9 and three-vessel disease
in 15) and 23 (20%) had angiographic collateral vessels. The
mean stenosis was 79 6 24%, including 32 patients (28%) with
100% stenosis, 70 (61%) with 50% to 99% stenosis and 13
(11%) with ,50% stenosis. Revascularization was done before
Figure 1. Diagram of infarction zones (dotted areas) in patients
according to (A) anterior (Ant) and (B) inferior, posterior or lateral
infarction location. LAX 5 long axis; SAX PM 5 short axis at papillary
muscle level; 4C 5 four chamber; 2C 5 two chamber; Sept 5 septal;
Post 5 posterior; Lat 5 lateral; Inf 5 inferior. (Reprinted, with
permission, from Smart et al. [16].)
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hospital discharge in 58 patients (50%)—angioplasty in 42 and
bypass surgery in 16. The clinical, angiographic and echocar-
diographic data of the 23 patients without follow-up echocar-
diograms were similar to the 115 patients with follow up
echocardiograms.
Reversible dysfunction by follow-up echocardiography.
During the first week after acute MI, baseline echocardiogra-
phy visualized 1,830 (99%) of 1,840 segments. Of the infarction
zone segments 688 (66%) of 1,035 were dysfunctional, includ-
ing 222 hypokinetic (21%), 456 akinetic (44%) and 10 dyski-
netic (1%) segments. Scar was noted in 77 (17%) of the 466
akinetic or dyskinetic segments. Wall thickening improved at
follow-up in 305 (44%) of the 688 dysfunctional segments. The
majority of hypokinetic segments (65% [144 of 222]) recov-
ered, whereas wall thickening resumed in only 35% (161 of
456, p , 0.01 vs. hypokinetic) of akinetic and 0% (0 of 10, p ,
0.01 vs. hypokinetic) of dyskinetic segments. At follow-up, the
10 dyskinetic segments demonstrated dyskinesia in five and
akinesia in five, but almost all (90% [9 of 10]) demonstrated
echocardiographic scar. Wall thickening also did not recover in
any of the scarred segments (0% [0 of 77]) at baseline.
According to the criterion of three or more segments, infarct
zone dysfunction was reversible in 65 (56%) of 115 patients at
follow-up.
Reversible dysfunction was not related to the interval from
acute MI to baseline echocardiography (Fig. 2). According the
prospective inclusion criteria of the first week after acute MI,
16 patients were studied at 2 days, 24 at 3 days, 24 at 4 days, 12
at 5 days, 16 at 6 days and 13 at 7 days. Baseline dysfunction
was similar irrespective of the interval from acute MI to
baseline echocardiography. Reversible dysfunction in both
hypokinetic and dyskinetic segments was not related to the
interval from acute MI to baseline echocardiography.
Dobutamine echocardiography. Dobutamine echocardiog-
raphy was performed the same day as baseline echocardiogra-
phy (4.5 6 2 days after acute MI). Rest heart rate and blood
pressure were 72 6 14 beats/min and 112 6 18 mm Hg,
respectively. Peak dose was 28 6 10 mg/kg per min. Atropine
was used in 40 patients. Heart rate and blood pressure at peak
dose were 115 6 15 beats/min and 135 6 28 mm Hg,
respectively. Heart rate .120 beats/min (n 5 57) or ischemic
end points (chest pain or .2 mm ST segment segment
deviation, n 5 27) were achieved in 84 (73%) of 115 patients.
Segmental data revealed that wall thickening improved at
the low dose in 328 (48%) of the 688 dysfunctional segments.
Improved wall thickening was more common (p , 0.01) in
hypokinetic (74% [165 of 222]) than akinetic (36% [163 of
456]) or dyskinetic (0% [0 of 10]) segments. The 328 segments
improving at the low dose consisted of 97 with sustained
improvement (30%) and 231 with biphasic responses (70%).
The prevalence of biphasic responses was similar in hypoki-
netic (66% [109 of 165]) and akinetic segments (75% [122 of
163]). The only determinant of the pattern of improvement
(sustained vs. biphasic) was infarct-related artery stenosis.
Responding segments from patients without residual stenosis
demonstrated sustained improvement in 75% (30 of 40) and
biphasic responses in only 25% (10 of 40). In contrast, biphasic
responses were more common in responding segments sup-
plied by infarct-related arteries with residual stenoses 50% to
Figure 2. Bar graph of the incidence of reversible dysfunction by
segmental function. Reversible dysfunction was not related to the
interval from acute MI to baseline DASE in both hypokinetic and
akinetic segments.
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99% and 100% (77% [156 of 203] and 76% [65 of 85],
respectively; p , 0.01 vs. no residual stenosis). Ischemic
responses were rare in dysfunctional segments. Only 19 (9%)
of 222 hypokinetic segments demonstrated no change at the
low dose and ischemic responses at peak dose. All 19 segments
(100%) demonstrating ischemic responses occurred in patients
with .70% infarct-related artery stenosis. Angiographic col-
lateral vessels were most common in ischemic (37% [7 of 19]),
unchanged (26% [90 of 341]) and biphasic segments (20% [46
of 231]). Collateral vessels were rare in segments demonstrat-
ing sustained improvement (1% [1 of 97], p , 0.001 vs. other
responses).
Sixty-seven (58%) of 115 patients demonstrated improved
infarct zone wall thickening at the low dose in three or more
segments. The pattern was sustained in 12, biphasic in 42 and
mixed in 13 patients. Only four of the 48 infarct zones that did
not change at the low dose demonstrated ischemic responses in
three or more dysfunctional segments at peak dose. The main
response of the infarct zone also reflected 1) the segmental
correlations of mixed, ischemic and biphasic responses with
residual stenosis (100% [13 of 13], 100% [4 of 4] and 95% [40
of 42], respectively vs. 89% [39 of 44] for no change and 50%
[6 of 12] for sustained improvement, p , 0.001) and 2) the
correlation of angiographic collateral vessels with ischemic
responses, biphasic responses and no change (19% [8 of 42],
50% [2 of 4] and 30% [13 of 44], respectively vs. 0% [0 of 13]
for mixed responses and 0% [0 of 12] for sustained improve-
ment, p , 0.0001).
Segmental data were used for analysis of the predictive
accuracy for reversible dysfunction and the causes of false
negative and false positive results. Most patients demonstrated
multiple segmental responses during DASE and at follow-up.
Multiple segmental responses during DASE were noted in 95
(83%) of 115 patients. The major infarct zone response only
reflected 467 (68%) of the 688 segmental responses. Thus, the
infarct zone data did not reflect 221 of the segments (32%) or
1.92 6 1.58 segments/patient (0 in 20 patients, 1 in 35 patients,
2 in 27 patients, 3 in 15 segments, 4 in 7 patients, 5 in 7 patients
and 6 in 4 patients).
Identification of reversible dysfunction. Table 1 compares
clinical, rest echocardiographic and angiographic factors ac-
cording to reversible and fixed segmental dysfunction. Univar-
iate clinical predictors of reversible dysfunction were lower rest
heart rate, female gender, low peak CK, non–Q wave and
nonanterior infarction, beta-blocker therapy and no history of
infarction. Thrombolytic therapy and younger age tended to be
associated with fixed dysfunction owing to a higher prevalence
of akinetic segments. Angiotensin-converting enzyme inhibitor
therapy was not predictive of reversible dysfunction. Univari-
ate rest echocardiographic predictors were absence of scar and
hypokinesia. Univariate angiographic predictors were single-
vessel disease and revascularization. Multivariate predictors
were only low peak CK, non–Q wave infarction, absence of
scar and hypokinesia.
Figure 3 plots the sensitivity, specificity and positive and
negative predictive values of DASE for reversible dysfunction
in the 688 dysfunctional segments. The changes at peak dose
did not enhance the accuracy of improved segmental wall
thickening at the low dose for reversible dysfunction. Biphasic
responses and sustained improvement were both specific and
Table 1. Comparison of Clinical, Rest Echocardiographic and Follow-Up Changes
Reversible
Dysfunction
(n 5 305)
Fixed
Dysfunction
(n 5 383)
Univariate
p Value
Multivariate
p Value
Clinical characteristics
Rest heart rate (beats/min) 71 6 13 75 6 15 0.002 NS
Peak CK (IU/ml) 1,694 6 1,632 2,982 6 2,276 ,0.0001 ,0.0001
Peak CK #1,500 IU/ml 59 (181) 33 (128) ,0.0001 NS
Non–Q wave MI 50 (153) 30 (113) ,0.0001 0.04
Age (yr) 59 6 13 56 6 13 0.01 NS
Gender (female) 17 (52) 10 (40) 0.02 NS
Beta-blocker 56 (171) 44 (167) 0.001 NS
Previous MI 12 (37) 24 (91) ,0.0001 NS
Nonanterior MI 57 (173) 48 (184) 0.03 NS
ACE inhibitor 24 (71) 26 (98) 0.5 NS
Thrombolysis 61 (186) 72 (276) 0.01 NS
Rest echocardiography
Scar 0 (0) 20 (77) ,0.0001 ,0.0001
Hypokinesia 47 (144) 20 (78) ,0.0001 ,0.0001
Angiography
IRA stenosis (%) 78 6 24 80 6 23 0.32 NS
Collateral vessels 17 (53) 24 (91) 0.051 NS
Single-vessel disease 59 (180) 49 (186) 0.006 NS
Revascularization 57 (174) 44 (170) 0.001 NS
Data are presented as mean value 6 SD or percentage (number) of segments. ACE 5 angiotensin-converting
enzyme; CK 5 creatine kinase; IRA 5 infarct-related artery; MI 5 myocardial infarction.
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positively predictive of reversible dysfunction. Biphasic re-
sponses were more sensitive than sustained improvement
owing to their greater prevalence. In contrast to these data,
ischemic responses in hypokinetic segments predicted fixed
dysfunction, especially in medically treated (100% [8 of 8] vs.
36% [4 of 11], p , 0.05).
Figure 4 plots the positive and negative predictive values in
improved wall thickening and shows no change according to
the test interval after acute MI. Improved wall thickening was
highly predictive of reversible dysfunction irrespective of the
test interval. The positive predictive value was slightly reduced
on the fourth day after infarction. Likewise, no change at the
low dose was highly predictive of fixed dysfunction irrespective
of the test interval.
Table 2 lists the accuracy of improved wall thickening at the
low dose and the incidence of true positive, false positive, true
negative and false negative results according to baseline dys-
function and clinical and angiographic factors. Dobutamine
echocardiography was accurate for reversible dysfunction in all
echocardiographic, clinical and angiographic subsets. True
Figure 3. Bar graph of the sensi-
tivity, specificity and positive and
negative predictive values (PPV
and NPV) of findings during
dobutamine-atropine stress echo-
cardiography for reversible dys-
function in the 688 dysfunctional
segments. Biphasic responses
and sustained improvement were
highly specific and positively pre-
dictive of reversible dysfunction.
Biphasic responses were more
common and sensitive than sus-
tained improvement. Improved
segmental wall thickening at the
low dose, irrespective of changes at
peak dose, was sensitive, specific
and highly predictive of reversible
dysfunction.
Figure 4. Bar graph of the positive
predictive value of improved wall
thickening (open bars) and the nega-
tive predictive value of no change
(solid bars) at the low dose (LD)
according to the test interval after
acute MI. Improved wall thickening at
the low dose (both sustained improve-
ment and biphasic responses) was pre-
dictive of reversible dysfunction, irre-
spective of the test interval. The
positive predictive value was slightly
reduced on the fourth day after infarc-
tion. Otherwise, there were no differ-
ences related to the test interval. No
change at the low dose (including
ischemic responses at peak dose and
no change at low and peak doses) was
predictive of fixed dysfunction, irre-
spective of the test interval. There
were no day to day differences in the
negative predictive value.
1674 SMART ET AL. JACC Vol. 30, No. 7
DASE FOR REVERSIBLE DYSFUNCTION AFTER MI December 1997:1669–78
positive and true negative responses were directly and in-
versely related, respectively, to the prevalence of reversible
dysfunction. Accuracy was directly related to the severity of
dysfunction and was significantly greater in akinetic and dys-
kinetic segments than in hypokinetic segments (p 5 0.0005).
Accuracy was also greater in segments perfused by arteries
without residual stenosis compared with segments with oc-
cluded infarct-related arteries (p 5 0.02). By multivariate
analysis, the only independent cause of reduced accuracy was
hypokinesia. The causes of false positive responses were
hypokinesia (p 5 0.00008), peak CK $1,500 IU/ml (p 5
0.0009), nonanterior infarction (p 5 0.02) and infarct-related
artery occlusion (p 5 0.04). By multivariate analysis, the only
independent cause of false positive results was hypokinesia.
Finally, false negative results were uncommon and not related
to any rest echocardiographic, clinical or angiographic factors.
Table 3 lists the stepwise multiple logistic regression anal-
ysis and ROC analysis of the incremental value of clinical, rest
echocardiographic and DASE findings in the detection of
reversible dysfunction after acute MI. Each set of findings
incrementally improved the predictive accuracy for reversible
dysfunction after acute MI. The clinical findings of a low peak
CK level or non–Q wave infarction were moderately predictive
of reversible dysfunction after acute MI. The rest echocardio-
graphic findings of no scar and hypokinesia significantly im-
proved the predictive accuracy, but accuracy was only maxi-
mized by the addition of dobutamine echocardiographic
findings of biphasic responses or sustained improvement.
Comparative analysis—observer variability. Kappa statis-
tic data revealed that intraobserver and interobserver variabil-
ities of baseline, dobutamine-atropine and follow-up echocar-
diographic interpretations were minimal. There was no
variability in the interpretation of infarction zone wall thick-
ening as normal or abnormal. In the 100 patients selected (598
dysfunctional segments), the kappa statistics for interobserver
variability of baseline, low dose, peak dose and follow-up
segmental readings were 0.745 (z 6 25.857, p , 0.0001), 0.741
(z 6 25.667, p , 0.0001), 0.702 (z 5 24.659, p , 0.0001) and
0.789 (z 5 26.156, p , 0.0001), respectively. The kappa
statistics for intraobserver variability of baseline, low dose,
peak dose and follow-up segmental readings were 0.793 (z 5
26.202, p , 0.0001), 0.802 (z 5 26.741, p , 0.0001), 0.780 (z 5
25.950, p , 0.0001) and 0.809 (z 5 26.865, p , 0.0001),
respectively. The interobserver reproducibility of segmental
readings at baseline, low dose, peak dose and follow-up were
92% (549 segments), 92% (548), 91% (543) and 93% (554),
Table 2. Subgroup Analysis of Accuracy for Reversible Segmental Dysfunction
No. of
Segments
Dobutamine Echocardiography
Accuracy
True
Positive
False
Positive
True
Negative
False
Negative
All segments 688 84 (581) 38 (263) 10 (65) 46 (318) 6 (42)
Hypokinetic segments 222 77 (171) 58 (129) 16 (36) 19 (42) 7 (15)
Akinetic segments 456 88 (400)* 29 (134) 6 (29)* 58 (266) 6 (27)
Dyskinetic segments 10 100 (10)* 0 (0) 0 (0) (10) 0 (0)
Previous MI 128 84 (108) 21 (27) 8 (10) 63 (81) 8 (10)
No previous MI 560 84 (473) 42 (236) 10 (55) 42 (237) 6 (32)
CK $1,500 IU/ml 379 83 (315) 29 (109) 13 (49)† 54 (206) 4 (15)
CK ,1,500 IU/ml 309 86 (266) 50 (154) 5 (16) 36 (112) 9 (27)
Beta-blocker 338 84 (284) 43 (147) 9 (30) 41 (137) 7 (24)
No beta-blocker 350 85 (297) 33 (116) 10 (35) 52 (181) 5 (18)
Anterior MI 334 86 (285) 33 (108) 7 (22)‡ 53 (177) 7 (24)
Inf, post or lat MI 357 83 (296) 43 (155) 12 (43) 44 (141) 5 (18)
Q wave MI 422 86 (363) 32 (137) 10 (44) 54 (226) 4 (15)
Non–Q wave MI 266 82 (218) 47 (126) 8 (21) 35 (92) 10 (27)
Thrombolysis 462 86 (396) 35 (161) 9 (41) 51 (235) 5 (25)
No thrombolysis 226 82 (185) 45 (102) 11 (24) 37 (83) 7 (17)
Occluded IRA 203 80 (163)§ 29 (59) 13 (26)§ 51 (104) 7 (14)
Residual stenosis\ 405 85 (344) 41 (167) 9 (36) 44 (177) 6 (25)
No IRA stenosis¶ 80 93 (74) 46 (37) 4 (3) 46 (37) 4 (3)
Collateral vessels 144 88 (126) 29 (41) 4 (6) 59 (85) 8 (12)
No collateral vessels 544 84 (455) 41 (222) 11 (59) 43 (233) 6 (30)
Revascularization 344 84 (288) 44 (152) 10 (34) 40 (136) 6 (22)
Medical therapy 344 85 (293) 32 (111) 9 (31) 53 (182) 6 (20)
Single-vessel CAD 366 84 (306) 43 (156) 10 (36) 41 (150) 6 (24)
Multivessel CAD 322 85 (275) 33 (107) 9 (29) 52 (168) 6 (18)
*p , 0.0001 versus hypokinetic segments. †p , 0.01 versus creatine kinase (CK) ,1,500 IU/ml. ‡p , 0.05 versus
anterior myocardial infarction (MI). §p , 0.05 versus no infarct-related artery (IRA) stenosis. \Infarct-related artery
stenosis 50% to 99%; ¶Lumen diameter stenosis ,50%. Data in last five columns are presented as percentage (number)
of segments. CAD 5 coronary artery disease; Inf 5 inferior; lat 5 lateral; post 5 posterior.
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respectively. The intraobserver reproducibility of segmental
readings at baseline, low dose, peak dose, and follow-up were
93% (555 segments), 93% (558), 92% (553) and 94% (560),
respectively.
Discussion
Previous studies. Reversible dysfunction. Reversible myo-
cardial dysfunction may result from postischemic dysfunction,
recurrent ischemia and reperfusion or sustained hypoperfu-
sion, but the major mechanism after acute MI is postischemic
injury. Recovery is usually spontaneous, but may not be
maximal for 4 weeks or more (14–20,30). The reversibility of
dysfunction after acute MI may have important prognostic and
management implications (31). Thus, the early differentiation
of reversible from fixed dysfunction may be very useful in the
clinical management of these patients. Large infarct size or
extensive fixed akinesia or dyskinesia confers a poor prognosis,
irrespective of the use of revascularization, but prognosis in
extensive reversible dysfunction may be improved by early
infarct-related artery revascularization (31).
Dobutamine echocardiography. Clinical and angiographic
data are poorly predictive (2,16–20,32), but dobutamine echo-
cardiography is highly predictive of reversible dysfunction after
acute MI (16–20). Pierard et al. (17) reported that dobutamine
echocardiography and positron emission tomography were
concordant, sensitive and specific for reversible dysfunction in
17 patients treated with thrombolysis for acute anterior MI.
Another study of 51 patients treated with thrombolysis re-
vealed that accuracy was high in both anterior and nonanterior
infarctions (16). Other small studies reported a higher sensi-
tivity, especially in patients treated with angioplasty, and a
greater specificity than with rest thallium-201 single-photon
emission computed tomographic scintigraphy (18–20).
Several important issues regarding DASE for reversible
dysfunction early after acute MI remain to be investigated. Its
safety has been documented (22), but none have investigated
its limitations or the predictive value of the multiple segmental
responses from low to peak dose. No change at low dose is very
predictive of fixed dysfunction after acute MI, but the predic-
tive values of sustained improvement and biphasic and isch-
emic responses are unclear (16–20).
Present study. Reversible dysfunction. The present study
was sufficiently large to investigate the determinants of revers-
ible dysfunction after acute MI. Follow-up echocardiography 4
to 8 weeks after hospital discharge is an established technique
for documenting recovery of function and was not confounded
by recurrent ischemic events (30).
The interval from acute MI to echocardiography during the
first week after acute MI did not influence the incidence of
reversible dysfunction. The rates of reversible dysfunction in
hypokinetic and akinetic segments and the number and sever-
ity of dysfunctional segments were similar throughout the first
week after acute MI. Thus, recovery of reversibly injured
myocardium mainly occurred after the first week of convales-
cence.
Clinical and angiographic factors were only moderately
predictive of reversible dysfunction after acute MI. Reversible
dysfunction was less common in infarct-related artery occlu-
sion, Q wave infarction, multivessel coronary artery disease,
peak CK .1,500 IU/ml, previous MI and treatment without
beta-blockers. Reversible dysfunction was also less common
after thrombolytic therapy, owing to more severe injury (i.e., a
greater prevalence of akinetic segments). Angiographic collat-
eral vessels were a marker of residual stenosis rather than
reversible dysfunction, consistent with previous data (28).
Finally, the data were very consistent with postischemic injury
as the major mechanism of reversible dysfunction because
revascularization only modestly increased its incidence.
Rest segmental function and morphology by echocardiog-
raphy were modestly predictive of reversible dysfunction. Most
hypokinetic segments recovered and none of the dyskinetic or
scarred segments recovered. In the remaining major subset
(akinetic segments without scar), reversible dysfunction could
only be differentiated from fixed dysfunction by further testing.
Dobutamine-atropine echocardiography. Dobutamine-
atropine echocardiography accurately detected reversible dys-
function during the first week after acute MI. Both biphasic
Table 3. Stepwise Analysis of the Incremental Value of Clinical, Rest and Dobutamine
Echocardiographic Variables in the 688 Dysfunctional Segments in Detecting Reversible Dysfunction
Step Variable
Multiple Logistic
Regression ROC Analysis
Incremental
Chi-Square
Incremental
p Value
Area Under
ROC Curve
Incremental
p Value
1 Clinical
(peak CK ,1,500 IU/ml or non–Q wave MI) 74.5 ,0.0001 0.684 ,0.0001
2 Rest echocardiography
(no scar or hypokinesia) 144.3 ,0.0001 0.798 ,0.0001
3 DASE
(biphasic response or sustained
improvement)
240.1 ,0.0001 0.920 ,0.0001
DASE 5 dobutamine-atropine stress echocardiography; ROC 5 receiver operating characteristic; other abbrevia-
tions as in Table 1.
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responses and sustained improvement were predictive of re-
versible dysfunction and no change of fixed dysfunction, irre-
spective of the test interval. Ischemic responses were uncom-
mon but were predictive of fixed dysfunction, especially in
medically treated patients. Again, the major role of postisch-
emic injury in reversible dysfunction after acute MI was
implied by the similar predictive values found with revascular-
ization and medical treatment. The similar predictive values of
sustained improvement and biphasic responses indicated that
the low dose data were adequate to accurately detect reversible
dysfunction.
Dobutamine-atropine echocardiography accurately de-
tected reversible dysfunction in subsets with low and high rates
of reversible dysfunction and improved the detection of revers-
ible dysfunction compared with clinical, angiographic and rest
echocardiographic data. The independent cause of reduced
accuracy was rest hypokinesia, due to a high incidence of false
positive results. Reversible dysfunction was also common in
hypokinetic segments, so testing for reversible dysfunction had
limited value. False negative studies were not related to the
test interval, baseline dysfunction or clinical or angiographic
factors. Accuracy and predictive values were especially high in
the important subset of akinetic segments. The high accuracy
in infarct-related artery occlusion may have resulted from
optimal hemodynamic data or greater retrograde myocardial
blood flow (33,34). Testing had no value in dyskinetic segments
because none recovered.
The data from this study contrast with those reported by
Alfridi et al. (21) in patients with chronic left ventricular
dysfunction undergoing revascularization. These investigators
showed that biphasic responses predicted reversible dysfunc-
tion, but that sustained improvement predicted fixed dysfunc-
tion and ischemic responses predicted reversibility. The cur-
rent study demonstrated that biphasic responses predicted
reversible dysfunction, but that sustained improvement also
predicted reversibility, whereas ischemic responses predicted
fixed dysfunction.
The different results reflect the different mechanisms of
dysfunction. Chronic dysfunction that is salvageable by revas-
cularization is mediated by hypoperfusion or repetitive isch-
emia (21,35–37). In contrast, acute dysfunction that will re-
cover with or without revascularization is mediated by
postischemic or reperfusion injury (38–41). Biphasic responses
are highly predictive of coronary artery disease, so its high
predictive value for reversibility in both chronic dysfunction
and acute MI reflects the high prevalence of coronary disease
in the two groups (42–44). Sustained improvement is highly
predictive of noninfarct-related muscle and the absence of
inducible ischemia or coronary disease (42–44). Thus, it was
highly predictive of reversibility after acute MI because reper-
fusion injury rather than myopathy was the major mechanism.
In contrast, chronically dysfunctional segments that demon-
strate sustained improvement remain fixed because nonisch-
emic myopathy rather than reperfusion injury is the major
mechanism. Ischemic responses in dysfunctional segments are
also predictive of coronary stenosis (42–44). The moderate
predictive value of ischemic responses for reversible dysfunc-
tion in the study by Alfridi et al. (21) reflects the greater
prevalence of dysfunction due to hypoperfusion or repetitive
ischemia in their patients, as well as universal revasculariza-
tion.
Study limitations. Twenty-three patients were lost to
follow-up, but their clinical, angiographic and echocardio-
graphic findings were similar to those of the other study
patients. Therefore, lack of follow-up in these patients did not
introduce a selection bias. Follow-up angiography was not
performed. The goal of the study was to detect reversible
dysfunction. There were no clinical signs of restenosis or
recurrent ischemia in any patients, so documentation of
infarct-related artery patency was not done. Follow-up echo-
cardiography was done before the peak incidence of restenosis
(45). Bypass surgery was done in 16 of the 58 revascularized
patients. The peak heart rate was (mean 6 SD) 115 6 15
beats/min and beta-blockers were not stopped for the test.
Thus, the incidence of biphasic and ischemic responses may
have been higher with higher heart rates, but maximal peak
heart rates or an ischemic end point was achieved in 73% of
patients.
Clinical implications and conclusions. Dobutamine-atropine
echocardiography accurately detected reversible dysfunction
early after acute MI. Its only limitation was reduced accuracy
due to false positive results in hypokinetic segments. False
negative results were uncommon and not related to any
clinical, echocardiographic or angiographic factor. Reversible
dysfunction was common in hypokinetic segments and never
occurred in scarred or dyskinetic segments, so testing yielded
little clinical benefit in these subsets. Dobutamine-atropine
echocardiography was better than rest function and clinical
and angiographic data for the early detection of reversible
injury, owing to its high accuracy in akinetic segments. No
change and ischemic responses were predictive of fixed dys-
function. Sustained improvement and biphasic responses were
predictive of reversible dysfunction. The test interval and
clinical and angiographic factors did not affect accuracy.
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